Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Olga Zhdankin
Observed name:
O Zhdankin
Observed institutions:
University of Minnesota,
University of Minnesota, Duluth
OpenAlex ID:
A5000225133
Estrogen receptor-positive mammary tumorigenesis in TGFα transgenic mice progresses with progesterone receptor loss
2007
·
T A Rose-Hellekant
, M D Schroeder
, et al.
·
Oncogene
·
25
Molecular characterizations of Nop16 in murine mammary tumors with varying levels of c-Myc
2011
·
Donald W. Kundel
, Emily Stromquist
, et al.
·
Transgenic Research
·
9
Short-term Prophylactic Tamoxifen Reduces the Incidence of Antiestrogen-Resistant/Estrogen Receptor–Positive/Progesterone Receptor–Negative Mammary Tumors
2009
·
Teresa A. Rose-Hellekant
, Andrew J. Skildum
, et al.
·
Cancer Prevention Research
·
6
Supplementary Figure 1 from Short-term Prophylactic Tamoxifen Reduces the Incidence of Antiestrogen-Resistant/Estrogen Receptor–Positive/Progesterone Receptor–Negative Mammary Tumors
2023
·
Teresa A. Rose-Hellekant
, Andrew J. Skildum
, et al.
Supplementary Figure 1 from Short-term Prophylactic Tamoxifen Reduces the Incidence of Antiestrogen-Resistant/Estrogen Receptor–Positive/Progesterone Receptor–Negative Mammary Tumors
2023
·
Teresa A. Rose-Hellekant
, Andrew J. Skildum
, et al.
PDF
Data from Short-term Prophylactic Tamoxifen Reduces the Incidence of Antiestrogen-Resistant/Estrogen Receptor–Positive/Progesterone Receptor–Negative Mammary Tumors
2023
·
Teresa A. Rose-Hellekant
, Andrew J. Skildum
, et al.
Data from Short-term Prophylactic Tamoxifen Reduces the Incidence of Antiestrogen-Resistant/Estrogen Receptor–Positive/Progesterone Receptor–Negative Mammary Tumors
2023
·
Teresa A. Rose-Hellekant
, Andrew J. Skildum
, et al.
Abstract A15: Immunohistochemical patterns of the breast developmental gene, ELF5, reveals differential expression in high grade hormone receptor negative clinical breast cancer
2015
·
Donald Kundel
, Melanie Bomier
, et al.
·
Cancer Prevention Research
Abstract A03: Tumorigenesis involving expansion of CD24 high CD61 cells is abrogated by tamoxifen in mouse models of luminal breast cancer
2013
·
Olga Zhdankin
, Melanie Bomier
, et al.
·
Cancer Prevention Research
Abstract B004: Expansion of lineage negative, CD24high, CD61+ mammary cells is an early step in mammary tumorigenesis in NRL-TGFalpha and MMTV-c-neu but not MMTV-c-myc models of luminal breast cancer
2013
·
Olga Zhdankin
, Melanie Bomier
, et al.
·
Molecular Cancer Research
Abstract B88: Local delivery of breast cancer chemopreventives using mesenchymal stem cells
2010
·
Amy Greene
, Donna Parke
, et al.
·
Cancer Prevention Research
Abstract A197: Development of an immunocompetent, triple negative, breast cancer model for stem cell based delivery of therapeutics
2009
·
Amy Greene
, Donna Parke
, et al.
·
Molecular Cancer Therapeutics
Show more works
View as search
Works count:
12
Citation count:
40
H-index:
3
I10-index:
1
Year
Topic
Type